Fate Therapeutics Inc (FATE)
$3.17 -$0.02 (-0.63%) 10:29 PM 07/06/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$360.85M -
Day's Range
$3.09 - $3.17 -
Volume
2,255,673 -
52 Week Low / High
$1.63 - $8.83 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
FATE's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 4
- Strong Buy
- 2
- Buy
- 11
- Hold
- 1
- Sell
- 0
- Strong Sell
- $7.28
- Target Price
Company News
-
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) — Jul 2nd, 2024
Fate Therapeutics, Inc. SAN DIEGO, July 02, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with...
|
$